| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |